Chondromix
Also known as: Cartilage peptide complex
Chondromix (also called Cartilage peptide complex) is a bioregulator. Chondromix is a marketed blend rather than a defined single compound, sold for cartilage and joint support. It has no single molecular mechanism because its composition is a mixture, and formulations differ between suppliers.
For research use only.
Key Facts
- CAS
- 168608-25-7
- Molecular Weight (MW)
- 408.47 g/mol
- Half-life
- Not established
- FDA status
- Not Approved
- Administration Route
- —
- Frequency
- —
- Last updated
- Sep 26, 2026
- Reviewed
- Aug 30, 2026
- Targets
- Cartilage matrix (claimed)
Research summary
Marketed cartilage-support peptide blend rather than a single characterised active ingredient, with composition varying between suppliers. Because it is a mixture, no single mechanism, sequence or pharmacokinetic profile applies to it, and no pivotal trial has evaluated any branded product under this name. Not FDA-approved and not a treatment for arthritis or joint disease.
Peptide Library's Chondromix profile summarises 2 cited studies listed in the Science section, the compound's regulatory status, and research-protocol parameters reported for it. It is a research reference, not medical advice.
Protocol
- Dosage Range
- Not established for human therapy
- Frequency
- —
- Cycle
- —
- Administration Route
- —
- Reconstitution Guide
- —
Not yet checked against primary sources
These figures are compiled from earlier reference material. They have not been verified against FDA labelling, registered trials or published literature, no citation is attached to them, and none of them is a recommended dose. Chondromix is queued for dosage evidence review.
Compare reported doses across the whole librarySequence & molecular data
| Molecular formula | C15H28N4O7S |
|---|---|
| Molecular weight | 408.47 g/mol |
| CAS number | 168608-25-7 |
| Half-life | Not established |
| Appearance | White lyophilized powder |
| Formulation | Lyophilized Powder |
Identifiers link to the public PubChem, FDA Substance Registration (UNII), ChEMBL and DrugBank records for the same entity.
Science
Mechanism of Action
Chondromix is a marketed blend rather than a defined single compound, sold for cartilage and joint support. It has no single molecular mechanism because its composition is a mixture, and formulations differ between suppliers. Where it contains Khavinson-series peptides such as Cartalax, the proposed mechanism is that series' hypothesis of short peptides interacting with DNA promoter regions to influence chondrocyte gene expression — a claim resting on cell-culture and cytogenetic work from one research group. No pivotal trial has evaluated any branded Chondromix product, and the pharmacokinetics of the combination are uncharacterised.
Origin
Commercial peptide mixture; not a monographed drug.
Targets
Regulatory & research status
Chondromix is not an FDA-approved product. It is sold for laboratory research and has no approved medical use.
| FDA status | Not Approved |
|---|---|
| Availability | Research-Only |
| WADA (sport) | Unknown / Not Listed |
| Library classification | Research-Only |
Benefits
Chondromix side effects
Side Effects
- Unknown; product-dependent
Storage & stability
Lyophilized (freeze-dried) peptide powder is far more stable than the reconstituted solution. Keep sealed vials cold, dry and away from light; long-term storage is typically frozen, with short-term refrigeration for vials in use.
Once reconstituted in bacteriostatic water, keep the solution refrigerated, avoid repeated freeze–thaw cycles and agitation, and label the vial with the reconstitution date and concentration. Discard any solution that turns cloudy or shows particulates.
Degradation rates differ by sequence: peptides containing methionine, cysteine, asparagine or glutamine are more prone to oxidation and deamidation, so shelf life after reconstitution is compound-specific rather than universal.
Read the full guide: how to store peptides before and after reconstitution →
Source: Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544–575. (PMID 20143256). General guidance for research handling; not product-specific instructions.
Chondromix: frequently asked questions
What is Chondromix?
Marketed cartilage-support peptide blend rather than a single characterised active ingredient, with composition varying between suppliers. Because it is a mixture, no single mechanism, sequence or pharmacokinetic profile applies to it, and no pivotal trial has evaluated any branded product under this name. Not FDA-approved and not a treatment for arthritis or joint disease.
How does Chondromix work?
Chondromix is a marketed blend rather than a defined single compound, sold for cartilage and joint support. It has no single molecular mechanism because its composition is a mixture, and formulations differ between suppliers.
Is Chondromix FDA approved?
No. Chondromix is not approved by the FDA for any indication and is categorised as research-only. It has not been reviewed for safety or efficacy as a medicine, and published research should be read as investigation rather than established use.
What peptides are similar to Chondromix?
Compounds most often compared with Chondromix include Bonomarlot, Bronchogen, Cardiogen and Cartalax. They are grouped by shared mechanism or research area rather than by equivalence, and their regulatory status and evidence base differ.
References
- Class-level evidence — Peptides and AgeingExternal reference
- Class-level evidence — Tissue-specific effects of peptidesExternal reference
Related research, comparisons & guides
Related peptides
Compiled by Peptide Library Editorial · Reviewed Aug 30, 2026 · Updated Sep 26, 2026 · Version 2
This Chondromix profile is compiled from published literature (2 cited studies linked above), public regulatory records and chemical registries. It describes what research reports; it is not medical advice, and nothing here is a dosing recommendation for humans. Peptide Library does not sell peptides. Editorial policy · How profiles are compiled · Report an error
Track Chondromix research, inventory and reconstitution in the free Peptide Library app. Get the app for iOS or Android →